标题
Emerging issues related to COVID-19 vaccination in patients with cancer
作者
关键词
-
出版物
Oncology and Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-17
DOI
10.1007/s40487-021-00157-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A rationale to prioritise vaccination of HSCT patients against COVID-19
- (2021) Mathieu Leclerc et al. Lancet Haematology
- Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
- (2021) Eun‐Ju Lee et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach
- (2021) Constance D. Lehman et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
- (2021) M.C. Garassino et al. ANNALS OF ONCOLOGY
- Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action
- (2021) Chiara Corti et al. EUROPEAN JOURNAL OF CANCER
- COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
- (2021) Joyce K. Hwang et al. Journal of Hematology & Oncology
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Adjuvantation helps to optimise COVID-19 vaccine candidate
- (2021) Jing-Xin Li et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity
- (2021) Juliana D Siqueira et al. Virus Evolution
- Supportive care in patients with cancer during the COVID-19 pandemic
- (2021) M. Aapro et al. ESMO Open
- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
- (2021) Alvin J. X. Lee et al. BRITISH JOURNAL OF CANCER
- Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
- (2021) Johannes Oldenburg et al. Hamostaseologie
- US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
- (2021) Isaac See et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recommendations for the clinical and laboratory diagnosis of vaccine‐induced immune thrombotic thrombocytopenia (VITT) for SARS‐CoV‐2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
- (2021) Ishac Nazy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
- (2021) Søren Dinesen Østergaard et al. LANCET
- Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
- (2021) Robert H Shaw et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Cancer and COVID-19 vaccines: a complex global picture
- (2021) Aasim Yusuf et al. LANCET ONCOLOGY
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Mix-and-match COVID vaccines trigger potent immune response
- (2021) Ewen Callaway NATURE
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
- (2021) Aakash Desai et al. Nature Reviews Clinical Oncology
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control
- (2021) Kathleen M. Neuzil NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
- (2021) Douglas B. Cines et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- (2021) Anton Pottegård et al. BMJ-British Medical Journal
- The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
- (2021) Marcin F Osuchowski et al. Lancet Respiratory Medicine
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- (2021) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Vaccines in Patients With Cancer—A Welcome Addition, but There Is Need for Optimization
- (2021) Eleni Korompoki et al. JAMA Oncology
- Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19
- (2021) Anna Brodziak et al. Vaccines
- Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis
- (2021) Marco Tagliamento et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics
- (2021) Kamal S Saini et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
- (2020) Kamal S. Saini et al. BRITISH JOURNAL OF CANCER
- Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak
- (2020) Marco Tagliamento et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effect of the COVID-19 pandemic on cancer treatment and research
- (2020) Kamal S Saini et al. Lancet Haematology
- Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
- (2020) Xin Wang et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search